Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Pirmohamed M"'
Autor:
Kiguba R; Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda kiguba@gmail.com., Mwebaza N; Department of Pharmacology and Therapeutics, College of Health Sciences, Makerere University, Kampala, Uganda., Ssenyonga R; Department of Epidemiology & Biostatistics, College of Health Sciences, Makerere University, Kampala, Uganda., Ndagije HB; National Pharmacovigilance Centre, National Drug Authority, Kampala, Uganda., Nambasa V; National Pharmacovigilance Centre, National Drug Authority, Kampala, Uganda., Katureebe C; AIDS Control Programme, Ministry of Health, Kampala, Uganda., Katumba K; MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda., Tregunno P; Vigilance and Risk Management of Medicines, Medicines and Healthcare Products Regulatory Agency, London, UK., Harrison K; Vigilance and Risk Management of Medicines, Medicines and Healthcare Products Regulatory Agency, London, UK., Karamagi C; Clinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda., Scott KA; MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, UK., Pirmohamed M; MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, UK.
Publikováno v:
BMJ open [BMJ Open] 2022 Jul 01; Vol. 12 (7), pp. e061725. Date of Electronic Publication: 2022 Jul 01.
Autor:
Pushpakom S; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom., Kolamunnage-Dona R; Department of Biostatistics, University of Liverpool, United Kingdom., Taylor C; Clinical Trials Research Centre, University of Liverpool, United Kingdom., Foster T; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom., Spowart C; Clinical Trials Research Centre, University of Liverpool, United Kingdom., García-Fiñana M; Department of Biostatistics, University of Liverpool, United Kingdom., Kemp GJ; Liverpool Magnetic Resonance Imaging Centre, University of Liverpool, United Kingdom., Jaki T; Department of Mathematics and Statistics, Lancaster University, United Kingdom., Khoo S; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom., Williamson P; Department of Biostatistics, University of Liverpool, United Kingdom., Pirmohamed M; Department of Molecular and Clinical Pharmacology, University of Liverpool, United Kingdom.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 May 06; Vol. 70 (10), pp. 2062-2072.
Autor:
Carr DF; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Bourgeois S; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK., Chaponda M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi., Takeshita LY; Institute of Integrative Biology, University of Liverpool, Liverpool, UK., Morris AP; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.; Department of Biostatistics, University of Liverpool, Liverpool, UK., Castro EM; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Alfirevic A; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Jones AR; Institute of Integrative Biology, University of Liverpool, Liverpool, UK., Rigden DJ; Institute of Integrative Biology, University of Liverpool, Liverpool, UK., Haldenby S; Centre for Genomic Research, University of Liverpool, Liverpool, UK., Khoo S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, UK., Heyderman RS; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi.; Division of Infection and Immunity, University College London, London, UK., Dandara C; Division of Human Genetics, University of Cape Town, Cape Town, South Africa., Kampira E; Division of Human Genetics, University of Cape Town, Cape Town, South Africa., van Oosterhout JJ; Malawi-Liverpool-Wellcome Trust Clinical Research Programme, College of Medicine, University of Malawi, Malawi.; Dignitas International, Zomba, Malawi., Ssali F; Joint Clinical Research Centre, Headquarters, Kampala, Uganda., Munderi P; UVRI/MRC Uganda Research Unit on AIDS, Entebbe, Uganda., Novelli G; Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy., Borgiani P; Department of Biomedicine and Prevention, University of Rome 'Tor Vergata', Rome, Italy., Nelson MR; GlaxoSmithKline, Research Triangle Park, NC, USA., Holden A; SAEC Consortium, Ltd, Chicago, IL, USA., Deloukas P; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.; Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders (PACER-HD), King Abdulaziz University, Jeddah, 21589, Saudi Arabia., Pirmohamed M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2017 Apr 01; Vol. 72 (4), pp. 1152-1162.
Autor:
Nightingale S; Institute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK. s.nightingale@liv.ac.uk.; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK. s.nightingale@liv.ac.uk.; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK. s.nightingale@liv.ac.uk., Geretti AM; Institute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK., Beloukas A; Institute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK., Fisher M; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK., Winston A; St Marys' Hospital, Imperial College Healthcare NHS Trust, London, UK., Else L; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Nelson M; St Stephen's AIDS Research Trust and Chelsea and Westminster Hospital NHS Foundation Trust, London, UK., Taylor S; Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust, Birmingham, UK., Ustianowski A; North Manchester General Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK., Ainsworth J; North Middlesex University Hospital NHS Trust, London, UK., Gilson R; Research Department of Infection and Population Health, University College London, London, UK., Haddow L; Research Department of Infection and Population Health, University College London, London, UK., Ong E; Victoria Royal Infirmary, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK., Watson V; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Leen C; Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK., Minton J; Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Post F; Kings College Hospital NHS Foundation Trust, London, UK., Pirmohamed M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Solomon T; Institute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK.; Walton Centre for Neurology and Neurosurgery, Liverpool, UK., Khoo S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.; Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
Publikováno v:
Journal of neurovirology [J Neurovirol] 2016 Dec; Vol. 22 (6), pp. 852-860. Date of Electronic Publication: 2016 May 18.
Autor:
Nightingale S; Institute of Infection and Global Health, University of Liverpool, UK; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK; Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK. Electronic address: s.nightingale@liv.ac.uk., Michael BD; Institute of Infection and Global Health, University of Liverpool, UK; Walton Centre for Neurology and Neurosurgery, Liverpool, UK., Fisher M; Brighton and Sussex University Hospitals NHS Trust, UK., Winston A; St Marys' Hospital, Imperial College Heathcare NHS Trust, London, UK., Nelson M; St Stephen's AIDS Research Trust and Chelsea and Westminster Hospital NHS Foundation Trust, UK., Taylor S; Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust, UK., Ustianowski A; North Manchester General Hospital, Pennine Acute Hospitals NHS Trust, UK., Ainsworth J; North Middlesex University Hospital NHS Trust, UK., Gilson R; Research Department of Infection and Population Health, University College London, UK., Haddow L; Research Department of Infection and Population Health, University College London, UK., Ong E; Victoria Royal Infirmary, Newcastle upon Tyne Hospitals NHS Trust, UK., Leen C; Royal Infirmary of Edinburgh, NHS Lothian, UK., Minton J; Leeds General Infirmary, Leeds Teaching Hosptials NHS Trust, UK., Post F; Kings College Hospital NHS Foundation Trust, London, UK., Beloukas A; Institute of Infection and Global Health, University of Liverpool, UK., Borrow R; Vaccine Evaluation Unit at the Health Protection Agency (HPA) North West, Manchester, UK., Pirmohamed M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Geretti AM; Institute of Infection and Global Health, University of Liverpool, UK., Khoo S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Solomon T; Institute of Infection and Global Health, University of Liverpool, UK; Walton Centre for Neurology and Neurosurgery, Liverpool, UK.
Publikováno v:
Cytokine [Cytokine] 2016 Jul; Vol. 83, pp. 139-146. Date of Electronic Publication: 2016 Apr 28.
Autor:
Pushpakom SP; Department of Molecular and Clinical Pharmacology, The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, UK Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Taylor C; Clinical Trials Research Centre, University of Liverpool, Liverpool, UK., Kolamunnage-Dona R; Clinical Trials Research Centre, University of Liverpool, Liverpool, UK Department of Biostatistics, University of Liverpool, Liverpool, UK., Spowart C; Clinical Trials Research Centre, University of Liverpool, Liverpool, UK., Vora J; Department of Diabetes and Endocrinology, The Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK., García-Fiñana M; Department of Biostatistics, University of Liverpool, Liverpool, UK., Kemp GJ; Magnetic Resonance and Image Analysis Research Centre, University of Liverpool, Liverpool, UK., Whitehead J; Department of Mathematics and Statistics, Lancaster University, Lancaster, UK., Jaki T; Department of Mathematics and Statistics, Lancaster University, Lancaster, UK., Khoo S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK., Williamson P; Clinical Trials Research Centre, University of Liverpool, Liverpool, UK Department of Biostatistics, University of Liverpool, Liverpool, UK., Pirmohamed M; Department of Molecular and Clinical Pharmacology, The Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, UK Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Publikováno v:
BMJ open [BMJ Open] 2015 Oct 15; Vol. 5 (10), pp. e009566. Date of Electronic Publication: 2015 Oct 15.
Autor:
Pirmohamed M; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom. Electronic address: munirp@liverpool.ac.uk., Ostrov DA; Department of Pathology, Immunology and Laboratory Medicine, University of Florida College of Medicine, University of Florida, Gainesville, Fla., Park BK; Department of Molecular and Clinical Pharmacology, MRC Centre for Drug Safety Science, University of Liverpool, Liverpool, United Kingdom.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2015 Aug; Vol. 136 (2), pp. 236-44.
Autor:
Dickinson L; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom., Chaponda M, Carr DF, van Oosterhout JJ, Kumwenda J, Lalloo DG, Pirmohamed M, Heyderman RS, Khoo SH
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2014; Vol. 58 (2), pp. 706-12. Date of Electronic Publication: 2013 Nov 11.
Autor:
Pushpakom SP; NIHR Biomedical Research Centre, Royal Liverpool Hospital, Liverpool, UK. sudeepp@liv.ac.uk, Owen A, Back DJ, Pirmohamed M
Publikováno v:
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2013 Aug; Vol. 23 (8), pp. 438-41.
Autor:
Carr DF; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK., la Porte CJ, Pirmohamed M, Owen A, Cortes CP
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2010 Sep; Vol. 65 (9), pp. 1889-93. Date of Electronic Publication: 2010 Jul 17.